Blackburn-based tissue business Accrol Group has posted a rise in underlying sales and has declared it is ready for growth following the delivery of a rapid turnaround plan.
For the year to April 30 2019, the listed business report underlying revenue of £116.7m compared to £115.3m in the previous year.
Its adjusted EBITDA rose from a loss of £5.8m to a profit of £1m. Losses before tax fell from £24.1m to £14m. Revenue fell from £139.7m to £119.1m.
Announcing the results, the business said: “Accrol is now profitable, cash generative and fit for purpose.”
Enjoyed this? Read more from Ged Henderson